Clinical Trial to Evaluate the Efficacy and Safety of CKD-390 Tablet

Clinical trial NCT02805738 · UNKNOWN

Trial details

NCT number: NCT02805738
Sponsor: Chong Kun Dang Pharmaceutical
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2016-04-01
Primary completion: 2017-11-01
Enrollment: 158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.